Emphasis was placed on BChE inhibition due to its increasing clinical relevance in the later stages of Alzheimer’s disease, where BChE expression is elevated in neurofibrillary tangles and amyloid plaques. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.